Navigation Links
'Surgery' looks at inventions and innovations by surgeons
Date:3/6/2008

Philadelphia, PA, March 6, 2008 Surgeons are uniquely positioned to recognize areas for improvement in patient care and to develop innovative solutions to meet those needs. However, even the most productive surgical researchers may lack the know-how to develop their insights into successful commercial products. A special symposium in the February issue of SURGERY (Volume 143, Number 2, February 2008) provides surgeons with expert insights into the process of developing their ideas into commercially viable products that will benefit large numbers of patientswhile providing a financial return to inventors, investors, and university research departments.

Invited by the editors of SURGERY (http://www.elsevier.com/wps/find/journaldescription.cws_home/623195/description#description), the symposium includes contributions from a cross-section of experts, including noted experts in copyright and intellectual property, technology transfer, biomedical engineering, and finance, as well as from surgeons experienced in translating research ideas into the marketplace.

With mounting financial pressures academic medical centers are seeking new ways to support their missions of education, patient care, and research. A key initial question is whether the idea is patentablethat is, truly new, useful, and non-obvious. Once an idea with commercial potential is recognized, it must be developed through the complex processes leading to commercialization.

The eleven articles in the symposium emphasize that surgeons who invent new products provide a positive service, bringing valuable ideas from concept to the patient's bedside. Without the arduous and painstaking process of commercializationincluding finding investors willing to take the financial risk of funding new technologiesinnovative techniques of clinical value will never be developed to the scale at which they can benefit large numbers of patients.

For surgeon-researchers used to academic freedom and research for its own sake, collaborating with industry raises some unaccustomed issues. An overarching issue is conflict of interest. Today, universities have strict policies regarding potential financial conflicts of interest. These policies play an essential role in minimizing research bias and protecting patients serving as research subjects. However, one article in the symposium argues that an obsessive focus on conflict-of-interest disclosures hinders the development of beneficial research and innovations.

The development of new health science technologies offers a rare combination of potentially large financial returns with true health care advances with a significant impact on patients. In an introductory note, SURGERY Co-Editors-in-Chief Andrew L. Warshaw and Michael G. Sarr write, "The Editors offer this compendium, evidence of a changing academic world, in the hopes that our novel, imaginative, and innovative nuggets will be recognized and their value realized."


'/>"/>

Contact: Maureen Hunter
m.hunter@elsevier.com
215-239-3671
Elsevier
Source:Eurekalert

Related medicine news :

1. Neurologic & Orthopedic Hospital of Chicago Ranked Among Top in Nation for Spine Surgery
2. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
3. Risk of surgery for lung cancer lower at teaching hospitals
4. Orthocrat Teams up With WebOps to Advance Orthopedic Pre-Surgery Planning
5. Scientists discover who is likely to get dry eye syndrome after LASIK surgery
6. Obese Children Face More Complications During Surgery
7. Mouse study: Real-time imaging device may improve surgery for congenital colon disease
8. Facial asymmetry persists despite surgery to correct congenital deformity
9. The danger of blindness after ophthalmic surgery
10. New York Plastic Surgeon Performs Pro Bono Surgery on Disadvantaged Patient Where Health Insurance Coverage Was Denied
11. Study finds spine surgery yields greater benefits over nonsurgical treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... , ... Maury Regional Health has announced a large-scale adoption of AccuVein vein ... Maury Regional Medical Center is making vein visualization part of their standard of care. ... more importantly, helps our staff members locate a vein that will provide good access ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD ... ultimately, a cure. , The grants are awarded through a competitive application process ... a wide array of backgrounds and expertise in all areas relevant to PD research. ...
(Date:8/16/2017)... Sacramento, CA (PRWEB) , ... August 16, 2017 ... ... ($10.99, paperback, 9781498499613; $5.99, eBook, 9781498499620    ) shares that during the time of a ... as reminding Strawn of God's love, and all the many ways God shows ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... ... pain afflicting 8 of 10 Americans at some point in their lives, some of us ... equally vexing condition stems from a variety of causes that can be effectively targeted by ... president of Atlantic Spine Center. , Nestled between your neck and lower back, the ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2017. The cash dividend ... October 27, 2017 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
Breaking Medicine Technology: